RAC
Click for more information
0.00% $1.55 race oncology ltd

Ann: Bisantrene Phase 2 AML Trial Successful Concludes, page-58

  1. Mason14
    1,021 Posts.
    lightbulb Created with Sketch. 11293
    clock Created with Sketch.
    01/08/24
    15:49
    Post #: 75029750
    Good post, my man.

    What I would say is that the clinical history for Bisantrene easily warrants a $2B AUD MC.

    You do not have to look far to see peers were sold for significantly more with considerably less.

    I think you would struggle to find another opportunity as large, derisked, and undervalued on the ASX.
    RAC Price at posting: $1.57 Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 31  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS Super PITch gold sponsor RSM Australia: Can Diggers & Dealers 2024 be key to reinvigorating IPO activity?
right-arrow Created with Sketch.
AVH Avita boosts skin restoration product portfolio with 'dermal matrix' – a kind of next-level gauze made of fake skin
right-arrow Created with Sketch.
IDA Indiana Resources to win US$90M from Tanzania following international lawsuit
right-arrow Created with Sketch.
MAG Magmatic defines 6km copper trend with grades of up to 6.5% at NSW prospect
right-arrow Created with Sketch.
DEG De Grey sees more production at Hemi with latest drilling at Crow, Aquila
right-arrow Created with Sketch.
LML Lincoln repositions Kookaburra for low-cost graphite delivery
right-arrow Created with Sketch.
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
(20min delay)
Last
$1.55 		Change
0.000(0.00%) 		Mkt cap ! $264.0M
Open High Low Value Volume
$1.55 $1.59 $1.53 $101.1K 64.92K

Buyers (Bids)

No. Vol. Price($)
4 15599 $1.55
 

Sellers (Offers)

Price($) Vol. No.
$1.59 2000 1
View Market Depth
Last trade - 16.10pm 01/08/2024 (20 minute delay) ?
RAC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.